(Q42814528)

7 November 2017

title

Advanced glycation end products suppress lysyl oxidase and induce bone collagen degradation in a rat model of renal osteodystrophy (English)

1 reference

7 November 2017

Chiharu Aoki

1

1 reference

7 November 2017

Kenta Uto

2

1 reference

7 November 2017

Kazuho Honda

3

1 reference

7 November 2017

Yoshiharu Kato

4

1 reference

7 November 2017

Hideaki Oda

5

1 reference

7 November 2017

language of work or name

1 reference

26 August 2013

1 reference

7 November 2017

published in

Laboratory Investigation

1 reference

7 November 2017

volume

93

1 reference

7 November 2017

issue

11

1 reference

7 November 2017

page(s)

1170-1183

1 reference

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Association of kidney function with incident hip fracture in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Renal function and risk of hip and vertebral fractures in older women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Chronic kidney disease and hip fracture-related mortality in older people in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Bone fragility and collagen cross-links.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Properties and Function of Lysyl Oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Advanced glycation end product modification of bone proteins and bone remodelling: hypothesis and preliminary immunohistochemical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Advanced glycation end-products pentosidine and N epsilon-carboxymethyllysine are elevated in serum of patients with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Effect of advanced glycation endproducts on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Metformin reverts deleterious effects of advanced glycation end-products (AGEs) on osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Advanced glycation endproduct-specific receptors in rat and mouse osteoblast-like cells: regulation with stages of differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Isolation and characterization of MC3T3-E1 preosteoblast subclones with distinct in vitro and in vivo differentiation/mineralization potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Nonenzymatic cross-linking pentosidine increase in bone collagen and are associated with disorders of bone mineralization in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Lysyl oxidase binds transforming growth factor-beta and regulates its signaling via amine oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Treatment of experimental renal osteodystrophy with pamidronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Multi-detector row CT imaging of vertebral microstructure for evaluation of fracture risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Effects of trabecular type and orientation on microdamage susceptibility in trabecular bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Quantitative microcomputed tomography assessment of intratrabecular, intertrabecular, and cortical bone architecture in a rat model of severe renal osteodystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

The influence of inflammation-mediated osteopenia (IMO) on the structure of rabbit bone and skin collagen fibrils

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

A role for lysyl oxidase regulation in the control of normal collagen deposition in differentiating osteoblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Bone changes in hemodialyzed uremic subjects. Comparative light and electron microscope investigations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Bone modelling processes at the endosteal surface of human femora. Scanning electron microscopical studies in normal bone and in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Post-translational control of collagen fibrillogenesis in mineralizing cultures of chick osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Regulation of lysyl oxidase by basic fibroblast growth factor in osteoblastic MC3T3-E1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Homocysteine and C-reactive protein levels in haemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Homocysteine suppresses the expression of the collagen cross-linker lysyl oxidase involving IL-6, Fli1, and epigenetic DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Effect of asymmetric dimethylarginine on osteoblastic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Building strong bones: molecular regulation of the osteoblast lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

Lysyl oxidase (lox) gene deficiency affects osteoblastic phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

A bridge to improving healthcare outcomes and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Increased risk of hip fracture among patients with end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Relationship between moderate to severe kidney disease and hip fracture in the United States

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Increased risk of mortality associated with hip fracture in the dialysis population

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Role of advanced glycation end products in adynamic bone disease in patients with diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Animal model of adenine-induced chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Direct maxacalcitol injection into hyperplastic parathyroids improves skeletal changes in secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Changes in chemical composition of cortical bone associated with bone fragility in rat model with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Three-dimensional analysis of the spine in autopsy cases with renal osteodystrophy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

The role of collagen in the declining mechanical properties of aging human cortical bone

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Morphometric analysis of type I collagen fibrils in the osteoid of osteogenesis imperfecta

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Structural alterations in rat skin and bone collagen fibrils induced by ovariectomy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Collagen fibril diameter and its relation to cross-linking of collagen in the skin of patients with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Corneal and scleral collagen fiber formation in vitro

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Renal osteodystrophy studies with scanning and transmission electron microscopy

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Regulation of lysyl oxidase expression in lung fibroblasts by transforming growth factor-beta 1 and prostaglandin E2

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Mechanisms for the formation of glycoxidation products in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

Advanced glycation end products (AGEs), but not high glucose, inhibit the osteoblastic differentiation of mouse stromal ST2 cells through the suppression of osterix expression, and inhibit cell growth and increasing cell apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2013.105

7 January 2021

10.1038/LABINVEST.2013.105

Identifiers

DOI

1 reference

7 November 2017

1 reference